Is there a place for β-lactams in the treatment of multidrug-resistant/extensively drug-resistant tuberculosis? Synergy between meropenem and amoxicillin/clavulanate

Author： Gonzalo Ximena   Drobniewski Francis  

Publisher： Oxford University Press

ISSN： 1460-2091

Source： Journal of Antimicrobial Chemotherapy, Vol.68, Iss.2, 2013-02, pp. : 366-369

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel Compounds and Drugs and Recent Patents in Treating Multidrug- Resistant and Extensively Drug-Resistant Tuberculosis

By  

Recent Patents on Anti-Infective Drug Discovery, Vol. 7, Iss. 2, 2012-08 ,pp. : 141-156

Bentham Science Publishers

Access to resources Recommend Favorite

Diagnosis and Treatment of Drug-Resistant Tuberculosis: State of the Art

By  

Current Respiratory Medicine Reviews, Vol. 13, Iss. 2, 2017-12 ,pp. : 73-81

Bentham Science Publishers

Access to resources Recommend Favorite

Multi-Drug Resistant Pulmonary Tuberculosis

By  

Current Respiratory Medicine Reviews, Vol. 2, Iss. 1, 2006-02 ,pp. : 53-57

Bentham Science Publishers

Access to resources Recommend Favorite

Effective multidrug-resistant tuberculosis treatment

By Nierengarten M.B.  

The Lancet Infectious Diseases, Vol. 3, Iss. 3, 2003-03 ,pp. : 118-118

Elsevier

Access to resources Recommend Favorite

Outcomes of clofazimine for the treatment of drug-resistant tuberculosis: a systematic review and meta-analysis

By Dey Teesta   Brigden Grania   Cox Helen   Shubber Zara   Cooke Graham   Ford Nathan  

Journal of Antimicrobial Chemotherapy, Vol. 68, Iss. 2, 2013-02 ,pp. : 284-293

Oxford University Press

Access to resources Recommend Favorite